Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
Acta Physiol (Oxf) ; 240(6): e14151, 2024 06.
Artículo en Inglés | MEDLINE | ID: mdl-38676357

RESUMEN

AIMS: Ischaemic heart disease remains a significant cause of mortality globally. A pharmacological agent that protects cardiac mitochondria against oxygen deprivation injuries is welcome in therapy against acute myocardial infarction. Here, we evaluate the effect of large-conductance Ca2+-activated K+ channels (BKCa) activator, Compound Z, in isolated mitochondria under hypoxia and reoxygenation. METHODS: Mitochondria from mice hearts were obtained by differential centrifugation. The isolated mitochondria were incubated with a BKCa channel activator, Compound Z, and subjected to normoxia or hypoxia/reoxygenation. Mitochondrial function was evaluated by measurement of O2 consumption in the complexes I, II, and IV in the respiratory states 1, 2, 3, and by maximal uncoupled O2 uptake, ATP production, ROS production, transmembrane potential, and calcium retention capacity. RESULTS: Incubation of isolated mitochondria with Compound Z under normoxia conditions reduced the mitochondrial functions and induced the production of a significant amount of ROS. However, under hypoxia/reoxygenation, the Compound Z prevented a profound reduction in mitochondrial functions, including reducing ROS production over the hypoxia/reoxygenation group. Furthermore, hypoxia/reoxygenation induced a large mitochondria depolarization, which Compound Z incubation prevented, but, even so, Compound Z created a small depolarization. The mitochondrial calcium uptake was prevented by the BKCa activator, extruding the mitochondrial calcium present before Compound Z incubation. CONCLUSION: The Compound Z acts as a mitochondrial BKCa channel activator and can protect mitochondria function against hypoxia/reoxygenation injury, by handling mitochondrial calcium and transmembrane potential.


Asunto(s)
Calcio , Mitocondrias Cardíacas , Animales , Ratones , Calcio/metabolismo , Mitocondrias Cardíacas/metabolismo , Mitocondrias Cardíacas/efectos de los fármacos , Masculino , Canales de Potasio de Gran Conductancia Activados por el Calcio/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Ratones Endogámicos C57BL , Hipoxia/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Consumo de Oxígeno/efectos de los fármacos , Oxígeno/metabolismo
2.
Fractal rev. psicol ; 28(3): 324-332, set.-dez. 2016. tab
Artículo en Portugués | LILACS, Index Psicología - Revistas | ID: biblio-840620

RESUMEN

Resumo Partindo da análise de prontuários de internação de crianças e adolescentes no Hospital Psiquiátrico São Pedro, em Porto Alegre, observa-se, nos motivos de internação, componentes essencialmente morais, sem uma relação específica com os diagnósticos. Tomando essa discrepância em análise, resgata-se, na obra de Michel Foucault, elementos que permitem a construção do conceito de "poder de normalização". Utilizando tal ferramenta conceitual, opera-se uma genealogia dos saberes e técnicas que fazem da internação psiquiátrica uma operação repleta de componentes morais, atentando para as forças que constituem esse campo no Hospital Psiquiátrico São Pedro.(AU)


Abstract Examining the hospitalization records of children and juveniles in the São Pedro Psychiatric Hospital, in Porto Alegre, one notices, in the hospitalization causes, essentialy moral aspects, with no specific relation to the diagnostics. Taking such discrepancy into analysis, we rescue, in the work of Michel Foucault, aspects which allow us to forge the notion of "power of normalization". Using such concept, we conduct a genealogic research of the knowledges and techniques that turn the psychiatric hospitalization into an operation full of moral components, paying attention to the forces that constitute such a field in the São Pedro Psychiatric Hospital.(AU)


Asunto(s)
Humanos , Hospitalización , Hospitales Psiquiátricos , Moral , Poder Psicológico , Psiquiatría
3.
Rev. méd. Minas Gerais ; 14(1): 2-7, jan.-mar. 2004.
Artículo en Portugués | LILACS | ID: lil-575421

RESUMEN

O hipertireoidismo de origem auto-imune ou devido a doença autonômica da tireóide pode ser eficientemente controlado seja pela inibição temporária da hormoniogênese com as tiouréias, seja pela redução definitiva da massa folicular funcionante pela tireoidectomia ou administração de radioiodo. Com a intenção de conhecer os efeitos da radioiodoterapia na Faculdade de Medicina de Triângulo Mineiro, foram revisados 255 prontuários de pacientes com hipertireoidismo atendidos no ambulatório de tireóide entre janeiro de 1991 e 2001. O 1¹³¹ foi administrado a 61 pacientes portadores de doença de Basedow-Graves (DBG) (n=143), a seis com bócio multinodular tóxico (BMT) (n=17), e a 3 com bócio uninodular tóxico (BUI) (n=7). Apenas 1 caso de Hashitoxicese (n=40) de mais longa duração recebeu o mesmo tratamento. A maioria dos pacientes com DBG recebeu de 185 a 370MBq (5-10mCi) de 1¹³¹ e em dez pacientes com bócios volumosos foi necessário repetir a dose. Os pacientes com BMT e BUT receberam de 185 a 925MBg (5-25mCi) e uma segunda dose foi dada a três deles.Todos os pacientes foram curados do hipertireoidismo, não foram observadas complicações agudas, entretanto, o seguimento pós-dose até o momento detectou hipotireoidismo em 63% dos pacientes.


Hyperthyroidism either auto-immune or due to autonomic thyroid disease can be efficiently controlled by hormoniogenesis inhibition with antithyroid drugs or definitive reduction of functioning thyroid follicles number by either subtotal thyroidectomy or radioiodine administration. The effects of radioiodine therapy in the Triângulo Mineiro Medical School was investigated in 255 hyperthyroid patients treated between 1991 and 2001. 1¹³¹ was administered to 61 patients with Basedow-Graves disease (BGD), to six patients with multinodular toxic goiter (MTG), and to three patients with solitary toxic goiter (STG). Only one patient with Hashitoxicose ot unusual and longer duration received the same treatment. Patients with BGD were treated with 185 to 370MBq (5-10mCi) of 1¹³¹ but in ten of them with larger goiters it was necessary a second dose. Patients with MTG and STG received 185 to 925MBq (5-25mCi) and a second dose was given to three of them. All patients were considered cured from hyperthyroidism without acute complications, however follow up so far detected hypothyroidism in 63%.


Asunto(s)
Humanos , Enfermedad de Graves/radioterapia , Hipertiroidismo/radioterapia , Evaluación de Medicamentos , Brasil , Facultades de Medicina , Estudios Retrospectivos , Hipertiroidismo/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA